{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["9"],"submitter":["Shi R"],"pubmed_abstract":["<h4>Background</h4>As the pathogenesis of plurihormonal pituitary adenoma (PPA) is unclear and the diagnostic criteria are inconsistent, clinicians still find it challenging to diagnose. To analyze the relationship between clinical and pathological characteristics in PPA.<h4>Methods</h4>The clinical data of patients with 70 PPAs admitted during 2008-2010 and 2019-2020 were collected and analyzed. In particular, hormone examination using cell culture supernatant was performed to confirm PPA cases from 2019 to 2020.<h4>Results</h4>PPA accounted for 13% of all pituitary cases recorded in the same period. There were 30 men and 40 women. Fifty-three percent of patients had one endocrine manifestation, and 1% presented with two endocrine symptoms. However, none of the patients had three endocrin"],"journal":["Frontiers in surgery"],"pagination":["826720"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8913533"],"repository":["biostudies-literature"],"pubmed_title":["Clinicopathological Characteristics of Plurihormonal Pituitary Adenoma."],"pmcid":["PMC8913533"],"pubmed_authors":["Liu X","Yan Z","Shi R","Tan Z","Lei T","Wan X"],"additional_accession":[]},"is_claimable":false,"name":"Clinicopathological Characteristics of Plurihormonal Pituitary Adenoma.","description":"<h4>Background</h4>As the pathogenesis of plurihormonal pituitary adenoma (PPA) is unclear and the diagnostic criteria are inconsistent, clinicians still find it challenging to diagnose. To analyze the relationship between clinical and pathological characteristics in PPA.<h4>Methods</h4>The clinical data of patients with 70 PPAs admitted during 2008-2010 and 2019-2020 were collected and analyzed. In particular, hormone examination using cell culture supernatant was performed to confirm PPA cases from 2019 to 2020.<h4>Results</h4>PPA accounted for 13% of all pituitary cases recorded in the same period. There were 30 men and 40 women. Fifty-three percent of patients had one endocrine manifestation, and 1% presented with two endocrine symptoms. However, none of the patients had three endocrin","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2025-04-05T11:07:16.643Z","creation":"2025-04-05T11:07:16.643Z"},"accession":"S-EPMC8913533","cross_references":{"pubmed":["35284477"],"doi":["10.3389/fsurg.2022.826720"]}}